Serum content of the C-propeptide of the cartilage molecule type ii collagen in children

Clinical and Experimental Rheumatology

Volumn 15, Issue 3, 1997, Pages 325-328

  Carey, D E ^a,b,c   Alini, M ^d   Ionescu, M ^a   Hyams, J S ^e   Rowe, J C ^f   Rosenberg, L C ^g   Poole, A R ^a  

^a MCGILL UNIVERSITY   (Canada)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d ROYAL VICTORIA HOSPITAL   (Canada)

^e HARTFORD HOSPITAL   (United States)

^f UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

C propeptide; Cartilage; Type II collagen

Indexed keywords

COLLAGEN FIBRIL; COLLAGEN TYPE 2; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; ARTICLE; BONE DEVELOPMENT; CARTILAGE MATRIX; CHILD; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREMATURITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; CALCIUM-BINDING PROTEINS; CARTILAGE; CHILD; CHILD, PRESCHOOL; COLLAGEN; COLLAGEN TYPE II; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RADIOIMMUNOASSAY;

EID: 0031004376     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. HEINEGÅRD D, OLDBERG Å: Glycosylated matrix proteins. In: ROYCE PM, STEINMANN B (Eds.): Connective Tissue and Its Heritable Disorders. New York, Wiley-Liss Inc., 1993: 189-209.
2. POOLE AR: Cartilage in health and disease. In: MCCARTHY DJ, KOOPMAN WJ (Eds.): Arthritis and Allied Conditions, 12th edition, Philadelphia, Lea & Febiger 1993; 279-333.
3. HEINEGARD D, SAXNE T: Molecular markers of processes in cartilage in joint disease. Br J Rheumatol 1991; 30(Suppl. 1); 21-4.
4. THONAR EJ-MA, SHINMEI A, LOHMANDER LS: Body fluid markers of cartilage changes in osteoarthritis. Rheum Dis Clin North Am 1993; 19: 635-57.
5. POOLE AR: Immunochemical markers of joint inflammation, skeletal damage and repair. Where are they now? Ann Rheum Dis 1994; 53: 3-5.
6. HOLLANDER AP, HEATHFIELD TF, WEBBER C, IWATA Y, BOURNE R, RORABECK C, POOLE AR: Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994; 93: 1722-32.
7. MÄNSSON B, CAREY D, ALINI M, IONESCU M, ROSENBERG LC, POOLE AR, HEINEGARD D, SAXNE T: Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995; 95: 1071-7.
8. KIVIRIKKO KL, MYLLYLA R: Biosynthesis of the collagens. In: PIEZ KA, REDDI AH (Eds.): Extracellular Matrix Biochemistry, New York, Elsevier 1984; 83-118.
9. CHOI HO, TANG L-H, JOHNSON TL, PAL S, ROSENBERG L, REINER A, POOLE AR: Isolation and characterization of a 35,000 molecular weight subunit fetal cartilage matrix protein. J Biol Chem 1983; 258: 655-61.
10. POOLE AR, PIDOUX I, REINER A, et al.: Kniest dysplasia is characterized by an apparent abnormal processing of the C-propeptide of type II collagen resulting in imperfect fibril assembly. J Clin Invest 1988; 81: 579-89.
11. POOLE AR, PIDOUX I, REINER A, CHOI H, ROSENBERG LC: Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol 1984; 98: 54-65.
12. HINEK A, POOLE AR: The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin). J Bone Min Res 1988; 3: 421-9.
13. KUJAWA MJ, WEITZHANDLER M, POOLE AR, ROSENBERG L, CAPLAN AI: Association of the C-propeptide of type II collagen with mineralization of embryonic chick long bone and sternal development. Conn Tiss Res 1989; 23: 179-99.
14. ALINI M, MATSUI Y, DODGE GR, POOLE AR: The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calc Tissue Int 1992; 50: 327-35.
15. SHINMEI M, ITO K, MATSUYAMA S, YOSHIHARA Y, MATSUZAWA: Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1993; 1: 121-8.
16. VAN DER REST M, ROSENBERG LC, OLSEN BR, POOLE AR: Chondrocalcin is identical with the C-propeptide of type II collagen. Biochem J 1986; 237: 923-5.
17. NELSON F, REINER A, IONESCU M, BROOKS E, BOGOCH E, POOLE AR: The content of the C-propeptide of type II collagen in articular cartilage is an index of synthesis of this molecule which is increased in osteoarthritis. Trans Orthop Res Soc 1994; 19: 216.
18. HYAMS JS, CAREY DE, LEICHTNER AM, GOLDBERG BD: Type I procollagen as a biochemical marker of growth in children with inflammatory bowel disease. J Pediatr 1986; 109: 619-24.
19. RISTELLI J, NIEMI S, TRIVEDI P, MALNTAUSTA O, MOWAT AP, RISTELLI L: Rapid equilibrium radioimmunoassay for the amino terminal propeptide of human type III procollagen. Clin Chem 1988; 4: 715-8.
20. HINEK A, REINER A, POOLE AR: The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin). J Cell Biol 1987; 104: 1435-41.
21. DELMAS PD, CHATELAIN P, MALAVAL L, BONNE G: Serum bone Gla-protein in growth hormone deficient children. J Bone Mineral Res 1986; 1: 333-8.
22. COLE DEC, CARPENTER T, GUNDBERG CM: Serum osteocalcin concentrations in children with metabolic bone disease. J Pediatr 1985; 106: 770-6.
23. RIIS B, KRABBE S, CHRISTIANSEN C, CATHERWOOD BD, LEFTOS LJ: Bone turnover in male puberty: a longitudual study. Calcif Tissue Int 1985; 37: 213-7.
24. JOHANSEN JS, GIWERCMAN A, HARTWELL D, NIELSEN CT, PRICE PA, CHRISTIANSEN C, SKAKKEBAEK NE: Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor 1, and serum testosterone. J Clin Endocrinol Metab 1988; 67: 273-8.
25. RISTELLI J, RISTELLI L: Growth and collagen. Current Medical Literature. Growth and Growth Factors 1989;4:159-64.
26. SAXNE T, CASTRO F, RYDHOLM U, SVANTESSON H: Cartilage derived proteoglycan in body fluids of children. Inverse correlation with age. J Rheumatol 1989; 16: 1341-4.
27. THONAR EJ-MA, PACHMAN LM, LENZ ME, HAYFORD J, LYNCH P, KUETTNER KE: Age-related changes in the concentration of serum keratan sulfate in children. J Clin Chem Biochem 1988; 26: 57-63.
28. PACHMAN LM, GREEN OC, LENZ ME, HAYFORD J, THONAR EJ-MA: Increase in serum concentrations of keratan sulfate after treatment of growth hormone deficiency with growth hormone. J Pediatr 1990; 16: 400-3.
29. CAREY DE, ROWE JC, GOETZ CA, HORAK E, CLARK RM, GOLDBERG B: Growth and phosphorus metabolism in premature infants fed human milk, fortified milk, or special premature formula. Use of procollagen as a marker of growth. Am J Dis Child 1987; 141: 511-5.